{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "East Brunswick",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "96074",
      "recalling_firm": "Rising Pharma Holding, Inc.",
      "address_1": "2 Tower Center Blvd Ste 1401",
      "address_2": "",
      "postal_code": "08816-1149",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0190-2025",
      "product_description": "Duloxetine DR Capsules USP 60  mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-99) bottles; Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ",
      "product_quantity": "244,460 bottles",
      "reason_for_recall": "CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.",
      "recall_initiation_date": "20241230",
      "center_classification_date": "20250108",
      "report_date": "20250115",
      "code_info": "Lot # a) DT6023053A, DT6023061A, DT6023068A, DT6023074A, exp. date Jan-25;  DT6023078A, DT6023076A, exp. date Feb-25;  DTC24043A, DTC24044A, exp. date Dec-25   b) DT6023002A, DT6023016A, DT6023036A, exp. date Dec-24;  DT6023048A, exp. date Jan-25",
      "more_code_info": ""
    }
  ]
}